Ignite Creation Date:
2024-05-06 @ 4:30 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05007236
Status:
COMPLETED
Last Update Posted:
2022-04-21
First Post:
2021-08-09
Brief Title:
Study to Evaluate the Efficacy and Safety of Oral RP7214 a DHODH Inhibitor in Patients With Symptomatic Mild COVID-19 Infection
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Rhizen Pharmaceuticals SA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-09
First Submit QC Date:
August 9 2021
Study First Post Date:
2021-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-20
Last Update Post Date:
2022-04-21
Last Update Post Date Type:
ACTUAL